All news from Anaesthesiology

Treatment to Reduce Hepatitis C Infection

Millions of people were at risk of becoming infected with hepatitis C virus (HCV) who injected drugs. The impact of opioid substitution treatment ( OST ) and needle syringe programs ( NSP ) was quantified to reduce the risk. This first global review was published in the Cochrane Library Drug and Alcohol Review Group and the journal Addiction .

FDA Approves COPD Medication – Trelegy Ellipta

Trelegy Ellipta is a combination of fluticasone furoate, umeclidinium, and vilanterol.  FDA has approved this once-daily, single inhaler triple therapy for patients with COPD. According to a company news release, the approved indication includes patients with chronic bronchitis and emphysema. The patients who are on a fixed-dose combination of fluticasone furoate and vilanterol for air flow obstruction.

Zika Virus Test: A First FDA Approved Test Intended to Detect Zika Virus from Blood Donations

The U.S. Food and Drug Administration today approved the Cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors. It is intended for use by blood collection establishments to detect Zika virus in blood donations, not for the individual diagnosis of Zika virus infection.